Literature DB >> 14522407

Toll-like receptors in cardiovascular diseases.

Dominique de Kleijn1, Gerard Pasterkamp.   

Abstract

The Toll-like receptor family recognizes mostly exogenous ligands like bacterial lipopolysaccharides or DNA and activates the inflammatory cell. Evidence is accumulating that these Toll-like receptors are important in cardiovascular pathologies. Recently, expression of Toll-like receptors in arterial and myocardial cells has been shown and mouse knockout and human studies on polymorphisms point to a role of Toll-like receptor 4 in neointima formation and atherosclerosis. It is now becoming clear that these receptors not only serve as receptors for pathogen-associated molecular patterns but are also involved in the initiation and progression of cardiovascular pathologies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522407     DOI: 10.1016/s0008-6363(03)00348-1

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  32 in total

1.  Cyclic stretch enhances the expression of toll-like receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-kappaB pathway.

Authors:  Kou-Gi Shyu; Bao-Wei Wang; Chiu-Mei Lin; Hang Chang
Journal:  J Biomed Sci       Date:  2010-03-05       Impact factor: 8.410

2.  The putative tumor suppressor Zc3h12d modulates toll-like receptor signaling in macrophages.

Authors:  Shengping Huang; Dongfei Qi; Jian Liang; Ruidong Miao; Kentaro Minagawa; Tim Quinn; Toshimitsu Matsui; Daping Fan; Jianguo Liu; Mingui Fu
Journal:  Cell Signal       Date:  2011-10-20       Impact factor: 4.315

3.  Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi.

Authors:  Christine A Petersen; Katherine A Krumholz; Barbara A Burleigh
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Salvianolic acid B suppresses maturation of human monocyte-derived dendritic cells by activating PPARγ.

Authors:  Aijun Sun; Hongying Liu; Shijun Wang; Dazhuo Shi; Lei Xu; Yong Cheng; Keqiang Wang; Keji Chen; Yunzeng Zou; Junbo Ge
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

5.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

6.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.

Authors:  Kathrin S Michelsen; Michelle H Wong; Prediman K Shah; Wenxuan Zhang; Juliana Yano; Terence M Doherty; Shizuo Akira; Tripathi B Rajavashisth; Moshe Arditi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

Review 7.  Annexin A2: biology and relevance to the antiphospholipid syndrome.

Authors:  E Cockrell; R G Espinola; K R McCrae
Journal:  Lupus       Date:  2008-10       Impact factor: 2.911

8.  The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?

Authors:  A Graham Pockley; Stuart K Calderwood; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2009-04-09       Impact factor: 3.667

Review 9.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

10.  Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components.

Authors:  Jaya Talreja; Mohammad H Kabir; Michael B Filla; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.